Shanghai
Shanghai
Shanghai, China, China28 results · Page 1 of 2
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Neoadjuvant Chemotherapy Combined With Bispecific Antibody Versus Combined With Monoclonal Antibody in Locally Advanced NSCLC | Locally Advanced Non-Small Cell Lung Cancer | Recruiting | Phase 3 | 2026-10-07 | NCT07863999 | |
| Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer | Genital Diseases, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, adenocarcinoma, carcinoma, epithelial neoplasm, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder | Recruiting | Phase 1 | 2026-09-25 | NCT06801236 | |
| Vision Therapy Versus Prism Treatment in Small-angle Acute Acquired Concomitant Esotropia | Ocular Motility Disorders, cranial nerve neuropathy, esotropia, eye disorder, nervous system disorder, strabismus | Recruiting | Not applicable | 2026-09-04 | NCT06622044 | |
| Lymphocyte-sparing Thoracic Radiotherapy for Esophageal Squamous Cell Carcinoma | Digestive System Diseases, Digestive System Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, carcinoma, digestive system disorder, digestive system neoplasm, epithelial neoplasm, esophageal disorder, esophageal squamous cell carcinoma, neoplasm, squamous cell carcinoma, squamous cell neoplasm | Recruiting | Not applicable | 2026-08-11 | NCT06596954 | |
| Precision Regional Node Irradiation for Sentinel Node-positive Breast Cancer | Breast Cancer Invasive | Active, not recruiting | Not applicable | 2026-08-11 | NCT06583655 | |
| Sequential PEG-IFN for HBV After Ending RNA-targeted Regimens | Blood-Borne Infections, Chronic Disease, DNA Virus Infections, Digestive System Diseases, Disease Attributes, Hepadnaviridae infectious disease, Hepatitis, Chronic, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, chronic hepatitis B virus infection, hepatitis, hepatitis B virus infection, infectious disease, liver disorder, viral hepatitis, viral infectious disease | Recruiting | Not applicable | 2026-07-29 | NCT06923280 | |
| Rimegepant Plus Glofitamab and CD19 CAR-T Therapy in R/R LBCL | Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence | Not yet recruiting | Phase 2 | 2026-05-29 | NCT07613788 | |
| A Study of SKB518 in Patients With Advanced Solid Tumors | Advanced Solid Tumors | Recruiting | Phase 1 | 2026-05-08 | NCT06428331 | |
| Osimertinib Combined With Intracranial SRT for EGFR-Mutant NSCLC With Symptomatic Brain Metastases | Neoplasms by Site, Thoracic Neoplasms, brain disorder, bronchial neoplasm, bronchogenic carcinoma, central nervous system cancer, central nervous system disorder, lung disorder, lung neoplasm, neoplasm, nervous system disorder, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Active, not recruiting | Not stated | 2026-03-27 | NCT07491211 | |
| MZL-IPI Risk-adapted Targeted Therapy in Untreated MZL | B-cell neoplasm, Hemic and Lymphatic Diseases, Lymphoma, B-Cell, Marginal Zone, Neoplasms by Histologic Type, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm | Recruiting | Phase 2 | 2026-03-24 | NCT06793189 | |
| Efficacy and Safety of Tislelizumab Combined With Gemcitabine and Peraspartase in the Treatment of Patients With Primary Stage I-II NK/T Cell Lymphoma | ORR; OS; PFS | Enrolling by invitation | Not stated | 2026-03-04 | NCT07450040 | |
| A Single-Arm Study on the Efficacy of Sequential Chemoradiotherapy Followed by Surgery in Adult Nasal and Paranasal Sinus Rhabdomyosarcoma | ORR; OS; PFS | Enrolling by invitation | Not stated | 2026-03-04 | NCT07449949 | |
| Neural Mechanisms of Temporal Interference Stimulation on Improving Social Reward Function in Depression | depressive disorder | Recruiting | Not applicable | 2025-12-24 | NCT07287878 | |
| One-Month DAPT in CABG Patients | Chronic Coronary Disease | Recruiting | Phase 3 | 2025-12-22 | NCT05997693 | |
| Toripalimab Combined With Chemotherapy as Adjuvant Therapy for Incidental Small Cell Lung Cancer After Radical Resection of Lung Cancer: A Single-Center, Randomized Controlled Clinical Study Protocol Number: LungMate-033 | Disease Attributes, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, respiratory system disorder, respiratory tract neoplasm, small cell lung carcinoma | Not yet recruiting | Phase 2 | 2025-08-01 | NCT07097948 | |
| Tislelizumab Combined With Capecitabine for Nasopharyngeal Carcinoma With Residual EBV DNA After Radiotherapy | Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Otorhinolaryngologic Neoplasms, Pharyngeal Diseases, Stomatognathic Diseases, carcinoma, epithelial neoplasm, nasopharyngeal carcinoma, nasopharyngeal disorder, nasopharyngeal neoplasm, neoplasm, otorhinolaryngologic disease | Recruiting | Phase 2 | 2025-07-16 | NCT07067268 | |
| Allogenic Adipose-Derived Mesenchymal Stem Cells for the Treatment of Knee Osteoarthritis | arthritic joint disease, arthropathy, musculoskeletal system disorder, osteoarthritis, osteoarthritis, knee, rheumatic disorder | Recruiting | Phase 3 | 2025-07-16 | NCT06570291 | |
| Toric Intraocular Lens (IOL) Implantation for Management of Cataracts | Toric Intraocular Lens Stability; Visual Quality | Recruiting | Not stated | 2025-06-19 | NCT05797298 | |
| Bile Omics for Diagnosing Indeterminate Biliary Strictures | Biliary Tract Neoplasms, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, biliary tract disorder, carcinoma, cholangiocarcinoma, endocrine system disorder, epithelial neoplasm, gallbladder disorder, gallbladder neoplasm, malignant endocrine neoplasm, malignant pancreatic neoplasm, neoplasm, pancreas disorder, pancreatic neoplasm | Recruiting | Not stated | 2025-06-11 | NCT07007832 | |
| O-RADS MRI System on Early Detection of Ovarian Cancer | Adnexal Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, endocrine system disorder, female reproductive system disorder, female reproductive system neoplasm, gonadal disorder, malignant endocrine neoplasm, neoplasm, ovarian cancer, ovarian disorder | Active, not recruiting | Not stated | 2025-06-08 | NCT07009743 | |
| Phase Ⅱ Clinical Trial of Cadonilimab Combined With Anti-angiogenic Agents in Metastatic dMMR/MSI-H CRC | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colonic disorder, colonic neoplasm, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm | Recruiting | Phase 2 | 2025-06-04 | NCT07003022 | |
| High-dose Topotecan for Retinoblastoma With Recurrent or Refractory Vitreous Seed | Disease Attributes, Eye Diseases, Hereditary, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, epithelial neoplasm, eye disorder, neoplasm, neuroepithelial neoplasm, ocular cancer, primitive neuroectodermal tumor, retinal cancer, retinal disorder, retinoblastoma | Recruiting | Early phase 1 | 2025-05-15 | NCT06972602 | |
| A ReaL World Study of DS-8201 | Breast Cancer Metastatic; Treatment Efficacy | Active, not recruiting | Not stated | 2025-04-25 | NCT06945224 | |
| Lecanemab for Early Onset Familial Alzheimer's Disease | Alzheimer disease, brain disorder, central nervous system disorder, cognitive disorder, dementia, nervous system disorder, neurodegenerative disease, psychiatric disorder, tauopathy | Recruiting | Not stated | 2025-03-19 | NCT06883019 | |
| Standardized Antihypertensive Treatment Protocol | cardiovascular disorder, hypertensive disorder, vascular disorder | Not yet recruiting | Not applicable | 2025-01-24 | NCT06790927 |